Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Sensorion
< Previous
1
2
3
4
Next >
Sensorion to Present at the 44th Annual J.P. Morgan Healthcare Conference
Today 1:30 EST
From
Sensorion
Via
Business Wire
Sensorion Reports Independent Data Monitoring Committee Raises No Safety Concerns and Agrees to Continue SENS-501’s Audiogene Phase 1/2 Trial
December 08, 2025
From
Sensorion
Via
Business Wire
Sensorion Reports 2025 Half-Year Results, Provides Corporate Update and Announces Availability of Half-Year Report
September 17, 2025
From
Sensorion
Via
Business Wire
Sensorion Announces an Increase in Resources Allocated to the Liquidity Contract with Kepler Cheuvreux
August 15, 2025
From
Sensorion
Via
Business Wire
Sensorion Announces Its Participation In Upcoming Investor Conferences
July 31, 2025
From
Sensorion
Via
Business Wire
Sensorion Completes Patient Enrollment of the Second Cohort in Audiogene Phase 1/2 Gene Therapy Clinical Trial
July 29, 2025
From
Sensorion
Via
Business Wire
Sensorion Announces Preliminary Positive Data from the First Cohort of the Audiogene Phase 1/2 Gene Therapy Clinical Trial
July 01, 2025
From
Sensorion
Via
Business Wire
Sensorion Publishes Results of Combined Shareholders’ General Meeting Resolutions
May 13, 2025
From
Sensorion
Via
Business Wire
Sensorion Announces its Participation in the American Society of Cell and Gene Therapy (ASGCT) Annual Meeting
May 06, 2025
From
Sensorion
Via
Business Wire
Sensorion Announces Presentation by Pr. Natalie Loundon at the 2025 American Society of Pediatric Otolaryngology Annual Meeting
April 25, 2025
From
Sensorion
Via
Business Wire
Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 12, 2025
April 18, 2025
From
Sensorion
Via
Business Wire
Sensorion to Host a Symposium during ISIET’s International Conference on Inner Ear Therapies on April 26, 2025
April 16, 2025
From
Sensorion
Via
Business Wire
Sensorion Strengthens Leadership Team with Appointment of Amit Munshi as Chairman of the Board and Independent Director
April 02, 2025
From
Sensorion
Via
Business Wire
Sensorion Announces Webconference, in French, for its Retail Shareholders on April 7, 2025
March 31, 2025
From
Sensorion
Via
Business Wire
Sensorion Announces its Participation at the Van Lanschot Kempen Conference Life Sciences
March 26, 2025
From
Sensorion
Via
Business Wire
Sensorion Reports Full-Year 2024 Results, Provides Corporate Update and Announces Availability of Full-Year Report
March 14, 2025
From
Sensorion
Via
Business Wire
Sensorion Announces the End of Patient Inclusion in NOTOXIS Phase 2a Clinical Trial of SENS-401 for the Prevention of Cisplatin-Induced Ototoxicity
March 07, 2025
From
Sensorion
Via
Business Wire
Sensorion Receives Positive Recommendation from Data Monitoring Committee of SENS-501’s Audiogene Phase 1/2 Clinical Trial
February 21, 2025
From
Sensorion
Via
Business Wire
Sensorion Announces Its Participation in Several Investor Conferences to be Held in March
February 20, 2025
From
Sensorion
Via
Business Wire
Sensorion Announces Its Participation In Several Congresses To Be Held In March
February 18, 2025
From
Sensorion
Via
Business Wire
Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 48th Annual Midwinter Meeting
February 12, 2025
From
Sensorion
Via
Business Wire
Sensorion Announces Completion of Enrollment of The First Cohort of The Audiogene Phase 1/2 Gene Therapy Clinical Trial
December 27, 2024
From
Sensorion
Via
Business Wire
Sensorion Reports Data in the Audiogene Phase 1/2 Gene Therapy Clinical Trial
December 18, 2024
From
Sensorion
Via
Business Wire
Sensorion to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 03, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces Its Participation in Upcoming Investor Conferences to be Held in November 2024
November 06, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces its Participation in the 31st Annual Congress of the European Society of Gene and Cell Therapy and the Presentation of Several Posters on GJB2-GT
October 17, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces Webconference for Retail Shareholders on October 10, 2024
September 26, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces the Availability of its Half Year 2024 Report
September 23, 2024
From
Sensorion
Via
Business Wire
Sensorion Reports New Positive Clinical Results Presented at the World Congress of Audiology
September 23, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces New Positive Clinical Data Across its Gene Therapy and Small Molecule Programs at the World Congress of Audiology in Paris
September 20, 2024
From
Sensorion
Via
Business Wire
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.